The ability to distinguish electrical stimulation of different electrodes on the basis of "pitch or sharpness" was evaluated with an electrode ranking procedure in 14 individual users of the Nucleus cochlear implant. Prior to the electrode ranking test, absolute thresholds and maximum comfortable loudness levels were measured, and loudness balancing was accomplished across all usable electrodes. Performance on the electrode ranking task was defined in terms of d' per mm of distance between comparison electrodes. Large individual differences were found among cochlear-implant users. In subjects with good to excellent place-pitch sensitivity, the electrode ranking task was limited by a ceiling effect; however, in those with poor to moderate sensitivity d'/mm was relatively constant with spatial separation between electrodes. Place pitch was typically ordered from apical to basal electrodes, i.e., basal electrodes were judged to be higher in pitch than more apical electrodes. However, instances of reversals in place-pitch ordering were seen on some electrodes in some subjects. Instances were also seen of better electrode ranking in the apical half of the electrode array than in the basal half, and vice-versa. Analyses of the electrode ranking functions in terms of d' per stimulus indicated that, in some subjects, perfect performance was reached with as little as 0.75 mm between comparison electrodes, the minimum possible. In other subjects, perfect performance was not reached until the spatial separation between comparison electrodes was over 13 mm, more than three quarters of the entire length of the electrode array. Ten of the subjects also participated in a closed-set recognition task of intervocalic consonants. Although the maximum transmitted information for place of consonant articulation (which is based primarily on spectral speech cues) was only 34%, correlations between place-pitch sensitivity and transmitted speech information were as high as 0.71. This was surprising considering the excellent place-pitch sensitivity exhibited by some of the subjects, and may reflect limitations of the Nucleus speech coding strategy for representing spectrally coded speech information. The two prelingual subjects performed notably poorer on the speech task than the postlingual subjects, even though one of the prelingual subjects demonstrated very good place-pitch sensitivity.
Otitis media (OM) is the most common childhood disease. Almost all children experience at least one episode, but morbidity is greatest in children who experience chronic/recurrent OM (COME/ROM). There is mounting evidence that COME/ROM clusters in families and exhibits substantial heritability. Subjects who had tympanostomy tube surgery for COME/ROM (probands) and their families were recruited for the present study, and an ear examination was performed, without knowledge of the subject's history, to determine presence of OM sequelae. In addition, tympanometric testing was performed at three frequencies (226, 630 or 710, and 1,400 Hz) to detect abnormal middle-ear mechanics, and hearing was screened at 20 dB for the speech frequencies. Of these families, 121 had at least two individuals who had received the diagnosis of COME/ROM (364 affected and genotyped individuals), of whom 238 affected and informative relative pairs were used for analyses. Single-point nonparametric linkage analysis provided evidence of linkage of COME/ROM to chromosome 10q at marker D10S212 (LOD 3.78; P=3.0 x 10(-5)) and to chromosome 19q at marker D19S254 (LOD 2.61; P=5.3 x 10(-4)). Analyses conditional on support for linkage at chromosomes 10q and 19q resulted in a significant increase in LOD score support on chromosome 3p (between markers D3S4545 and D3S1259). These results suggest that risk of COME/ROM is determined by interactions between genes that reside in several candidate regions of the genome and are probably modulated by other environmental risk factors.
Contemporary otomicrosurgical techniques have made total removal of acoustic tumor with preservation of the seventh and sometimes the eighth cranial nerves possible. The four approaches currently used in acoustic tumor surgery are the middle cranial fossa, the translabyrinthine, the suboccipital, and the combined translabyrinthine-suboccipital. This review examines the surgical results in the removal of more than 600 acoustic tumors and outlines a rationale for the choice of approach. Tumor size on computed tomographic scan and auditory reserve establish the parameters used in planning the surgical procedure. The translabyrinthine exposure is used most frequently followed by the combined translabyrinthine-suboccipital. The middle fossa and suboccipital approaches are used when preservation of hearing is attempted. Total removal of tumor was accomplished in more than 99% of patients with a mortality rate of less than 1%. Anatomic preservation of the facial nerve, which is directly related to tumor size, was achieved in more than 80% of patients. Preservation of hearing is unlikely when the tumor is larger than 2 cm; anatomic preservation of the cochlear nerve was successful in 73% of hearing preservation procedures.
To assess the efficacy, quality of life, and complication rate of cochlear implantation in patients over 60 years of age, we performed a retrospective chart review of 31 cochlear implant patients more than 60 years old at the time of surgery (mean, 70 years; range, 62 to 86 years). All patients had improvement in their audiological test results after operation. Twenty-eight patients (93%) are regular implant users at a median follow-up of 12 months. Major complications occurred in 2 patients (6%). We conclude that cochlear implantation in the elderly population has excellent results, with a complication rate similar to that in patients less than 60 years old, and yields an improved quality of life.KEY WORDS -cochlear implant, elderly, quality of life.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.